logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Sergiusz Nawrocki

university of warmia & mazury
H指数:17
被引数:1,292

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Durvalumab after radiotherapy in patients with unresectable stage III non-small-cell lung cancer ineligible for chemotherapy: the DUART phase II nonrandomized controlled study☆

度伐鲁单抗在不可切除的III期非小细胞肺癌且不符合化疗指征的患者放疗后的应用：DUART II期非随机对照研究☆

ESMO Open
IF8.3
2025-08-200
PREAI
A.R. Filippi; M.R. García Campelo; J.-B. Paoli; D. Kowalski; C. Bennati; P. Borghetti; D. Cortinovis; A. Delmonte; C. Genova; S. Van Hulst; R.M. Mroz; S. Nawrocki; I. Toledano; G. Tonini; F. Agustoni; G. Wetherill; Z. Zhu; I.D. Perez; K. Foroutanpour; N. Georgoulia; R. Dziadziuszko
Circulating tumor DNA (ctDNA) dynamics and treatment responses in chemotherapy-ineligible patients (pts) with unresectable stage III NSCLC from the phase II DUART trial

循环肿瘤DNA (ctDNA) 动态和治疗效果：来自II期DUART试验中不可切除III期NSCLC化疗不适宜患者（pts）的数据

ANNALS OF ONCOLOGY
IF65.4
2024-09-012
PRE
Filippi, A. R.; Garcia-Campelo, M. R.; Paoli, J-B.; Kowalski, D. M.; Bennati, C.; Borghetti, P.; Cortinovis, D. L.; Delmonte, A.; Genova, C.; Mroz, R. M.; Nawrocki, S.; Toledano, I.; Tonini, G.; Stewart, R.; Zhu, Z.; Wetherill, G.; Georgoulia, N. E.; Perez, I. Diaz; Dziadziuszko, R.
Durvalumab after radiotherapy (RT) in patients with unresectable stage III NSCLC ineligible for chemotherapy (CT): Primary results from the DUART study

不可切除的III期NSCLC患者放疗 (RT) 后的Durvalumab不适合化疗 (CT): DUART研究的主要结果

ANNALS OF ONCOLOGY
IF65.4
2023-10-012
OA
Filippi, A. R. R.; Garcia-Campelo, M. R.; Paoli, J. B.; Kowalski, D.; Bennati, C.; Borghetti, P.; Cortinovis, D. L.; Delmonte, A.; Genova, C.; Van Hulst, S.; Mroz, R.; Nawrocki, S.; Toledano, I.; Tonini, G.; Perez, I. Diaz; Georgoulia, N. E.; Foroutanpour, K.; Dziadziuszko, R.
Survival differences between the USA and an urban population from China for all cancer types and 20 individual cancers: a population-based study

美国和中国城市人群在所有癌症类型和20种个体癌症中的生存差异: 一项基于人群的研究

LANCET REGIONAL HEALTH-WESTERN PACIFIC
IF8.1
2023-08-014
OAAI
Fu, Ruiying; Sun, Ke; Wang, Xiaofeng; Liu, Bingsheng; Wang, Tao; Morze, Jakub; Nawrocki, Sergiusz; An, Lan; Zhang, Siwei; Li, Li; Wang, Shaoming; Chen, Ru; Sun, Kexin; Han, Bingfeng; Lin, Hong; Wang, Huinan; Liu, Dan; Wang, Yang; Li, Youwei; Zhang, Qian; Mu, Huijuan; Geng, Qiushuo; Sun, Feng; Zhao, Haitao; Zhang, Xuehong; Lu, Lingeng; Mei, Dan; Zeng, Hongmei; Wei, Wenqiang
Racial/ethnic disparities in the cause of death among patients with prostate cancer in the United States from 1995 to 2019: a population-based retrospective cohort study

美国2019年前列腺癌患者死因的种族/民族差异1995年: 一项基于人群的回顾性队列研究

ECLINICALMEDICINE
IF10
2023-08-018
OAAI
Zeng, Hongmei; Xu, Mengyuan; Xie, Yingwei; Nawrocki, Sergiusz; Morze, Jakub; Ran, Xianhui; Shan, Tianhao; Xia, Changfa; Wang, Yixin; Lu, Lingeng; Yu, Xue Qin; Azeredo, Catarina Machado; Ji, John S.; Yuan, Xiaomei; Curi-Quinto, Katherine; Liu, Yuexin; Liu, Bingsheng; Wang, Tao; Ping, Hao; Giovannucci, Edward L.

研究方向

暂未获取到该数据
A
Andrzej Maćkiewicz
H 指数:54论文数:339被引数:2.5万
M
Monika Rucińska
H 指数:13论文数:128被引数:533
G
Giuseppe Tonini
H 指数:85论文数:1,203被引数:3.4万
R
Rafał Dziadziuszko
H 指数:59论文数:603被引数:1.8万
K
Karolina Osowiecka
H 指数:13论文数:85被引数:375
A
Agnieszka Sopel
H 指数:0论文数:4被引数:0
I
I. Toledano
H 指数:7论文数:44被引数:423
L
Lingeng Lu
H 指数:58论文数:329被引数:1.1万
H
Hongmei Zeng
H 指数:65论文数:272被引数:4.0万
R
Robert Mróz
H 指数:21论文数:143被引数:5,054